Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.83 USD | +0.35% |
|
-3.08% | -63.01% |
06-27 | GT Biopharma Says FDA Clears Investigational New Drug Application for Cancer Drug GTB-3650 | MT |
06-27 | GT Biopharma Shares Rise on FDA Clearance for Cancer-Drug Study | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-63.01% | 6.08M | |
+55.32% | 819B | |
-6.75% | 351B | |
+13.56% | 329B | |
+10.68% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.48% | 168B | |
-2.81% | 158B |
- Stock Market
- Equities
- GTBP Stock
- News GT Biopharma, Inc.
- Roth Capital Cuts GT Biopharma to Neutral From Buy, Price Target to $3 From $9